Cargando…

Market competition among manufacturers of novel high-risk therapeutic devices receiving FDA premarket approval between 2001 and 2018

Detalles Bibliográficos
Autores principales: Rathi, Vinay K, Johnston, James L, Dhruva, Sanket, Ross, Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9923248/
https://www.ncbi.nlm.nih.gov/pubmed/36793371
http://dx.doi.org/10.1136/bmjsit-2022-000152
_version_ 1784887698280939520
author Rathi, Vinay K
Johnston, James L
Dhruva, Sanket
Ross, Joseph
author_facet Rathi, Vinay K
Johnston, James L
Dhruva, Sanket
Ross, Joseph
author_sort Rathi, Vinay K
collection PubMed
description
format Online
Article
Text
id pubmed-9923248
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-99232482023-02-14 Market competition among manufacturers of novel high-risk therapeutic devices receiving FDA premarket approval between 2001 and 2018 Rathi, Vinay K Johnston, James L Dhruva, Sanket Ross, Joseph BMJ Surg Interv Health Technol Regulatory and Policy Corner BMJ Publishing Group 2023-02-08 /pmc/articles/PMC9923248/ /pubmed/36793371 http://dx.doi.org/10.1136/bmjsit-2022-000152 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Regulatory and Policy Corner
Rathi, Vinay K
Johnston, James L
Dhruva, Sanket
Ross, Joseph
Market competition among manufacturers of novel high-risk therapeutic devices receiving FDA premarket approval between 2001 and 2018
title Market competition among manufacturers of novel high-risk therapeutic devices receiving FDA premarket approval between 2001 and 2018
title_full Market competition among manufacturers of novel high-risk therapeutic devices receiving FDA premarket approval between 2001 and 2018
title_fullStr Market competition among manufacturers of novel high-risk therapeutic devices receiving FDA premarket approval between 2001 and 2018
title_full_unstemmed Market competition among manufacturers of novel high-risk therapeutic devices receiving FDA premarket approval between 2001 and 2018
title_short Market competition among manufacturers of novel high-risk therapeutic devices receiving FDA premarket approval between 2001 and 2018
title_sort market competition among manufacturers of novel high-risk therapeutic devices receiving fda premarket approval between 2001 and 2018
topic Regulatory and Policy Corner
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9923248/
https://www.ncbi.nlm.nih.gov/pubmed/36793371
http://dx.doi.org/10.1136/bmjsit-2022-000152
work_keys_str_mv AT rathivinayk marketcompetitionamongmanufacturersofnovelhighrisktherapeuticdevicesreceivingfdapremarketapprovalbetween2001and2018
AT johnstonjamesl marketcompetitionamongmanufacturersofnovelhighrisktherapeuticdevicesreceivingfdapremarketapprovalbetween2001and2018
AT dhruvasanket marketcompetitionamongmanufacturersofnovelhighrisktherapeuticdevicesreceivingfdapremarketapprovalbetween2001and2018
AT rossjoseph marketcompetitionamongmanufacturersofnovelhighrisktherapeuticdevicesreceivingfdapremarketapprovalbetween2001and2018